title: Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.
abstract: The variation in immune responses to standard inoculation of the hepatitis-B virus vaccine suggest that host factors influence response in ways that are not presently understood. We studied 25 low/nonresponding health care workers (anti-HBs titer less than 50 IU/l) after the third inoculation of an experimental hepatitis-B vaccine to determine their immune status (through lymphocyte phenotypes) and HLA type. After application of a fourth inoculation, the seroconverting subjects showed only low anti-HBs levels; three male subjects remained anti-HBs negative. Twelve months after the fourth inoculation only 9 of 25 subjects (36%) maintained anti-HBs titer greater than 10 IU/l. Almost all subjects had normal B-cell and CD-4 and CD-8 counts and ratios. Relative to other European populations HLA-A-10 (P less than 0.05), B-12 (P less than 0.025), CW-5 (P less than 0.05), DR-3 (P less than 0.025), and DR-5 (P less than 0.025) were increased, whereas DR-2 (P less than 0.05) was decreased. However, after correction of the P-values for the number of HLA antigens determined, these differences were no longer significant. Furthermore, these HLA types were not the same as those reported in other studies (except for DR-3). We suggest that larger sample sizes or even not yet available immunogenetic markers will be required to prove an "immunogenetic background" in low/nonresponders, if it exists.
authors.affiliation: Medizinische Klinik und Poliklinik, Schwerpunkt Gastroenterologie, Freie Universität Berlin.
authors.forename: A
authors.initials: A
authors.lastname: Krämer
authors.forename: D
authors.initials: D
authors.lastname: Herth
authors.forename: H J
authors.initials: HJ
authors.lastname: von Keyserlingk
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: H
authors.initials: H
authors.lastname: Hampl
authors.forename: D
authors.initials: D
authors.lastname: Sommer
authors.forename: E G
authors.initials: EG
authors.lastname: Hahn
authors.forename: E O
authors.initials: EO
authors.lastname: Riecken
mesh_terms: D000293:Adolescent; D005260:Female; D006680:HLA Antigens / Q000235:genetics*; D006509:Hepatitis B / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines; D006801:Humans; D007117:Immunization, Secondary; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
chemical_list: D006680:HLA Antigens; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines